Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) EBT Margin (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed EBT Margin for 4 consecutive years, with 19.38% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 640475.0% to 19.38% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 158.16% through Dec 2025, up 215211.0% year-over-year, with the annual reading at 158.16% for FY2025, 215211.0% up from the prior year.
  • EBT Margin for Q4 2025 was 19.38% at Orchestra BioMed Holdings, up from 2419.05% in the prior quarter.
  • The five-year high for EBT Margin was 19.38% in Q4 2025, with the low at 6385.38% in Q4 2024.
  • Average EBT Margin over 4 years is 2080.46%, with a median of 1977.38% recorded in 2022.
  • The sharpest move saw EBT Margin crashed -344982bps in 2023, then surged 640475bps in 2025.
  • Over 4 years, EBT Margin stood at 891.02% in 2022, then plummeted by -387bps to 4340.84% in 2023, then plummeted by -47bps to 6385.38% in 2024, then skyrocketed by 100bps to 19.38% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 19.38%, 2419.05%, and 2316.15% for Q4 2025, Q3 2025, and Q2 2025 respectively.